SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-25
👔
Moleculin Biotech, Inc.
@MBRX_InsiderForm 4 Filing: Foster Jonathan P. Surrenders for Taxes $217.2 of $MBRX
TAX WITHHOLDING
⚡ MATERIALITY: 2/10
corporate issuer
Moleculin Biotech, Inc.
Ticker: $MBRX
Transaction Value
$217.2
Price/Share: $0.61
transaction date
2026-06-22
Shares: 355
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Foster Jonathan P., holds the title of Chief Financial Officer at Moleculin Biotech, Inc..
On 2026-06-22, the insider transacted 355 shares.The shares were transacted at a weighted average price of $0.61 per share, resulting in a total market-relevant value of $217.2.
Executive Summary Summary
Foster Jonathan P. (Chief Financial Officer) had withheld for taxes $217 of $MBRX
Post-Transaction Position: 12,340 shares
SEC Accession No: 0001437749-26-021610 (CIK: 1545414)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.